Natixis Advisors LLC boosted its stake in Monster Beverage Corporation (NASDAQ:MNST - Free Report) by 2.3% in the first quarter, according to the company in its most recent disclosure with the SEC. The firm owned 1,777,226 shares of the company's stock after purchasing an additional 40,422 shares during the quarter. Natixis Advisors LLC owned about 0.18% of Monster Beverage worth $104,003,000 as of its most recent filing with the SEC.
Other institutional investors have also recently bought and sold shares of the company. Wayfinding Financial LLC purchased a new stake in Monster Beverage during the first quarter worth approximately $29,000. Coppell Advisory Solutions LLC grew its stake in Monster Beverage by 259.2% during the fourth quarter. Coppell Advisory Solutions LLC now owns 686 shares of the company's stock worth $36,000 after buying an additional 495 shares during the period. Park Square Financial Group LLC purchased a new stake in Monster Beverage during the fourth quarter worth approximately $36,000. Migdal Insurance & Financial Holdings Ltd. grew its stake in Monster Beverage by 37.1% during the first quarter. Migdal Insurance & Financial Holdings Ltd. now owns 724 shares of the company's stock worth $42,000 after buying an additional 196 shares during the period. Finally, Banque Cantonale Vaudoise purchased a new stake in Monster Beverage during the first quarter worth approximately $43,000. 72.36% of the stock is currently owned by hedge funds and other institutional investors.
Monster Beverage Stock Up 0.5%
MNST traded up $0.27 during trading on Friday, hitting $59.02. The company had a trading volume of 12,248,440 shares, compared to its average volume of 5,052,162. The company has a market cap of $57.56 billion, a PE ratio of 38.83, a P/E/G ratio of 2.11 and a beta of 0.55. The business has a 50-day moving average of $61.83 and a 200-day moving average of $57.59. The company has a debt-to-equity ratio of 0.03, a current ratio of 3.37 and a quick ratio of 2.78. Monster Beverage Corporation has a 1-year low of $43.32 and a 1-year high of $64.45.
Monster Beverage (NASDAQ:MNST - Get Free Report) last posted its quarterly earnings results on Thursday, May 8th. The company reported $0.47 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.46 by $0.01. The firm had revenue of $1.85 billion for the quarter, compared to analysts' expectations of $1.97 billion. Monster Beverage had a net margin of 20.27% and a return on equity of 27.46%. The firm's quarterly revenue was down 2.3% on a year-over-year basis. During the same period in the prior year, the company posted $0.42 earnings per share. As a group, analysts forecast that Monster Beverage Corporation will post 1.62 earnings per share for the current year.
Insider Buying and Selling at Monster Beverage
In related news, insider Emelie Tirre sold 8,796 shares of the company's stock in a transaction on Friday, May 16th. The shares were sold at an average price of $62.46, for a total value of $549,398.16. Following the sale, the insider directly owned 89,501 shares of the company's stock, valued at $5,590,232.46. This represents a 8.95% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. Also, CFO Thomas J. Kelly sold 27,000 shares of the business's stock in a transaction on Thursday, May 29th. The shares were sold at an average price of $63.40, for a total transaction of $1,711,800.00. Following the sale, the chief financial officer owned 69,273 shares of the company's stock, valued at approximately $4,391,908.20. The trade was a 28.05% decrease in their position. The disclosure for this sale can be found here. Corporate insiders own 8.30% of the company's stock.
Wall Street Analyst Weigh In
Several equities research analysts have issued reports on MNST shares. JPMorgan Chase & Co. boosted their price objective on shares of Monster Beverage from $60.00 to $64.00 and gave the stock a "neutral" rating in a research note on Friday, May 9th. Truist Financial boosted their price objective on shares of Monster Beverage from $40.00 to $50.00 and gave the stock a "sell" rating in a research note on Wednesday, April 23rd. UBS Group boosted their price objective on shares of Monster Beverage from $63.00 to $64.00 and gave the stock a "neutral" rating in a research note on Thursday, July 17th. Roth Mkm boosted their target price on shares of Monster Beverage from $50.00 to $56.00 and gave the stock a "neutral" rating in a research report on Wednesday, May 14th. Finally, Wells Fargo & Company boosted their target price on shares of Monster Beverage from $67.00 to $70.00 and gave the stock an "overweight" rating in a research report on Friday, June 13th. Two analysts have rated the stock with a sell rating, nine have assigned a hold rating and thirteen have issued a buy rating to the company. Based on data from MarketBeat, the stock currently has a consensus rating of "Hold" and an average target price of $61.91.
Read Our Latest Stock Report on Monster Beverage
About Monster Beverage
(
Free Report)
Monster Beverage Corporation, through its subsidiaries, engages in development, marketing, sale, and distribution of energy drink beverages and concentrates in the United States and internationally. The company operates through three segments: Monster Energy Drinks, Strategic Brands, Alcohol Brands, and Other.
Recommended Stories

Before you consider Monster Beverage, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Monster Beverage wasn't on the list.
While Monster Beverage currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.